Paper Abstract:
This study evaluated individual differences in levels of C-reactive protein (CRP) measured in saliva, cross-sectionally and prospectively, in relation to systemic inflammation and risk for cardiovascular disease (CVD). Plasma and saliva samples, later assayed for CRP, were collected multiple times from an ethnically diverse group of women seeking help from domestic violence crisis shelters-agencies (N = 107; mean age at study start = 34 years). Plasma and saliva CRP levels were moderately associated cross-sectionally and across two years. There were indications that saliva CRP levels were, on average, higher in the morning than evening. Higher levels of saliva and plasma CRP were associated with a higher body mass index, but did not differ between women who did and did not smoke. Salivary CRP reliably discriminated between high and low levels of plasma CRP, using a clinically relevant cutoff point of 3 mg/L, recommended by the American Heart Association. Results build upon an emerging literature suggesting that under specific conditions levels of CRP in saliva may reflect low-grade inflammation and have the potential to serve as a screen for CVD risk status.
The Salimetrics Salivary C-Reactive Protein Assay can be located here:
http://www.salimetrics.com/my-spit-research/analytes/c-reactive-protein.php
*******
To discuss the purchase of Salimetrics Salivary Assay Kits, Saliva Collection Devices, Saliva Testing Service, Saliva Training Courses or to book an Educational Roadshow visit please contact:
Info@salimetricseurope.com
Salimetrics Europe Ltd Unit 7, Acorn Business Centre Oaks Drive, Newmarket Suffolk, CB8 7SY
T: +44 (0) 1638 782619 F: +44 (0) 1638 782618
In Australia, Asia Pacific please e-mail our Sydney office: info@stratechscientific.com.au
Websites: Europe, Africa, Middle East: www.salimetrics.com
Australia, Asia Pacific: www.stratechscientific.com.au